Rwanda Initiates Marburg Vaccine Trials Amid Rising Cases
Rwanda is set to commence clinical trials for vaccines and treatments against the Marburg viral disease, according to Health Minister Yvan Butera. The country confirmed the disease in September, resulting in 11 deaths and 36 reported cases so far.
- Country:
- Rwanda
Rwanda is on the verge of beginning clinical trials for vaccines and therapeutics aimed at combatting the Marburg viral disease, Health Minister Yvan Butera announced on Thursday.
The viral disease, officially identified in Rwanda in late September, has so far resulted in 11 fatalities, with a total of 36 cases reported, according to data from the health ministry.
The initiation of these trials marks a critical step in the country's ongoing efforts to control the outbreak and prevent further casualties.
(With inputs from agencies.)
Advertisement
ALSO READ
WHO Inks $1.5B Primary Health Financing Deal with Development Banks
HDFC Life Partners with Metropolis Healthcare and CallHealth for Seamless Pre-Policy Medical Check-ups
Top Health News: Drug Trials, Bird Flu, and Mpox Updates
Urgent Investment Needed to Address Rising Health Challenges for 1.3 Billion Adolescents, WHO Report Warns
Investing in Digital Health Could Save 2 Million Lives from Noncommunicable Diseases: WHO-ITU Report